Literature DB >> 3819811

Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs.

R L Fine, S Koizumi, G A Curt, B A Chabner.   

Abstract

Calcium channel blockers (CCBs) such as verapamil and nitrendipine are capable of increasing drug sensitivity in resistant murine and human tumor cells. This finding has potential value in the treatment of acquired drug resistance in human malignancies. Thus, we tested the ability of CCBs of two different structural classes to enhance the toxicity of doxorubicin (DOX), vinblastine (VBL), and vincristine (VCR) for normal myeloid and macrophage colony formation (marrow colony forming units-granulocyte-monocyte [CFU-GM]). Drug effects on colony formation from 35 normal volunteer marrows and from seven patient marrows in the recovery phase after cytotoxic chemotherapy were determined. No enhancement of toxicity was mediated by verapamil or nitrendipine when these drugs were co-incubated with the cytotoxic drugs for one hour or 24 hours before plating marrow cells in a semisolid agar system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819811     DOI: 10.1200/JCO.1987.5.3.489

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

1.  Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells.

Authors:  Stephan Hoffmann; Stephanie Balthasar; Ulrike Friedrichs; Marianne Ehren; Stephen J Ryan; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-09       Impact factor: 3.117

2.  In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors.

Authors:  S Hayashi; R L Fine; T C Chou; M J Currens; S Broder; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages.

Authors:  J Szebeni; S M Wahl; M Popovic; L M Wahl; S Gartner; R L Fine; U Skaleric; R M Friedmann; J N Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.

Authors:  F W Busch; U Schmittele; G Ehninger
Journal:  Blut       Date:  1990-04

5.  Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.

Authors:  S Hayashi; D W Norbeck; W Rosenbrook; R L Fine; M Matsukura; J J Plattner; S Broder; H Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

6.  Variable effects of tamoxifen on human hematopoietic progenitor cell growth and sensitivity to doxorubicin.

Authors:  K E Woods; S Grant; S Yanovich; D A Gewirtz
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.

Authors:  M A Smith; S Merry; J G Smith; S B Kaye
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

8.  A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer. West of Scotland Lung Cancer Research Group, and the Aberdeen Oncology Group.

Authors:  R Milroy
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.